Literature DB >> 24030613

The efficacy of cognitive-behavioral therapy and psychodynamic therapy in the outpatient treatment of major depression: a randomized clinical trial.

Ellen Driessen, Henricus L Van, Frank J Don, Jaap Peen, Simone Kool, Dieuwertje Westra, Mariëlle Hendriksen, Robert A Schoevers, Pim Cuijpers, Jos W R Twisk, Jack J M Dekker.   

Abstract

OBJECTIVE: The efficacy of psychodynamic therapies for depression remains open to debate because of a paucity of high-quality studies. The authors compared the efficacy of psychodynamic therapy with that of cognitive-behavioral therapy (CBT), hypothesizing nonsignificant differences and the noninferiority of psychodynamic therapy relative to CBT.
METHOD: A total of 341 adults who met DSM-IV criteria for a major depressive episode and had Hamilton Depression Rating Scale (HAM-D) scores ≥14 were randomly assigned to 16 sessions of individual manualized CBT or short-term psychodynamic supportive therapy. Severely depressed patients (HAM-D score >24) also received antidepressant medication according to protocol. The primary outcome measure was posttreatment remission rate (HAM-D score ≤7). Secondary outcome measures included mean posttreatment HAM-D score and patient-rated depression score and 1-year follow-up outcomes. Data were analyzed with generalized estimating equations and mixed-model analyses using intent-to-treat samples. Noninferiority margins were prespecified as an odds ratio of 0.49 for remission rates and a Cohen's d value of 0.30 for continuous outcome measures.
RESULTS: No statistically significant treatment differences were found for any of the outcome measures. The average posttreatment remission rate was 22.7%. Noninferiority was shown for posttreatment HAM-D and patient-rated depression scores but could not be demonstrated for posttreatment remission rates or any of the follow-up measures.
CONCLUSIONS: The findings extend the evidence base of psychodynamic therapy for depression but also indicate that time-limited treatment is insufficient for a substantial number of patients encountered in psychiatric outpatient clinics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24030613     DOI: 10.1176/appi.ajp.2013.12070899

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  28 in total

1.  What we know, what we do not know, and where are we heading? Efficacy and acceptability of psychological interventions for depression.

Authors:  N Solomonov; J P Barber
Journal:  Epidemiol Psychiatr Sci       Date:  2015-09-28       Impact factor: 6.892

2.  The efficacy and acceptability of psychological interventions for depression: where we are now and where we are going.

Authors:  Steven D Hollon
Journal:  Epidemiol Psychiatr Sci       Date:  2015-08-27       Impact factor: 6.892

3.  The effectiveness of psychodynamic psychotherapies: An update.

Authors:  Peter Fonagy
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

Review 4.  Genetic determinants of depression: recent findings and future directions.

Authors:  Erin C Dunn; Ruth C Brown; Yael Dai; Jonathan Rosand; Nicole R Nugent; Ananda B Amstadter; Jordan W Smoller
Journal:  Harv Rev Psychiatry       Date:  2015 Jan-Feb       Impact factor: 3.732

5.  Further Evidence for Short-Term Psychodynamic Therapy in Major Depressive Disorder.

Authors:  Falk Leichsenring; Christiane Steinert
Journal:  Can J Psychiatry       Date:  2017-01       Impact factor: 4.356

6.  Rating Short-Term Psychodynamic Therapy for the Canadian Network for Mood and Anxiety Treatments Depression Guidelines.

Authors:  Sagar V Parikh; Lena Quilty; Paula Ravitz; Michael Rosenbluth; Barbara Pavlova; Sophie Grigoriadis; Vytas Velyvis; Rudolf Uher; Sidney H Kennedy; Raymond W Lam; Glenda M MacQueen; Roumen Milev; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2017-01       Impact factor: 4.356

7.  Comparative Effectiveness of Cognitive Therapy and Dynamic Psychotherapy for Major Depressive Disorder in a Community Mental Health Setting: A Randomized Clinical Noninferiority Trial.

Authors:  Mary Beth Connolly Gibbons; Robert Gallop; Donald Thompson; Debra Luther; Katherine Crits-Christoph; Julie Jacobs; Seohyun Yin; Paul Crits-Christoph
Journal:  JAMA Psychiatry       Date:  2016-09-01       Impact factor: 21.596

Review 8.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments.

Authors:  Sagar V Parikh; Lena C Quilty; Paula Ravitz; Michael Rosenbluth; Barbara Pavlova; Sophie Grigoriadis; Vytas Velyvis; Sidney H Kennedy; Raymond W Lam; Glenda M MacQueen; Roumen V Milev; Arun V Ravindran; Rudolf Uher
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

9.  Predictors of treatment attendance in cognitive and dynamic therapies for major depressive disorder delivered in a community mental health setting.

Authors:  Mary Beth Connolly Gibbons; Robert Gallop; Donald Thompson; Averi Gaines; Agnes Rieger; Paul Crits-Christoph
Journal:  J Consult Clin Psychol       Date:  2019-06-17

Review 10.  Relapse prevention after index electroconvulsive therapy in treatment-resistant depression.

Authors:  Nagy A Youssef; W Vaughn McCall
Journal:  Ann Clin Psychiatry       Date:  2014-11       Impact factor: 1.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.